FDA OK for Apel’s Walrus balloon guide catheterSeptember 6, 2019
Q’Apel Medical LLC received US FDA clearance for its novel Walrus Balloon Guide Catheter (BGC).
In the neurovascular space where speed, reliability and performance are so critical to patient outcomes, physicians and patients demand that innovative technologies are best-in-class. The walrus BGC, with its 087 ID, marks a big step forward in balloon guide catheter technology and for stroke patients worldwide.
The walrus BGC represents the second FDA-cleared technology from Q’Apel in the past 12 months, joining the wahoo Access Catheter with Selectflex technology in Q’Apel’s expanding product portfolio.
Q’Apel is planning to launch several more innovative products in the market over the course of the next year.